Inside Sullivan & Worcester’s New York Team Visit to Taiwan
During the 2026 BIO Asia–Taiwan exhibition, a professional team from International law firm Sullivan & Worcester LLP made a dedicated visit to Taiwan. Over several intensive days, lawyers from their US Capital Markets met with Taiwanese companies, industry leaders and professionals to discuss topics ranging from the U.S. capital markets and cross-border fundraising to global expansion strategies and U.S. listings. With Sullivan, were a team of professionals representing different disciplines within the U.S. capital markets ecosystem.
Hall Chadwick Taiwan (耀風會計師事務所) was honored to help coordinate part of the team’s program in Taiwan and to participate in the exchanges. In just a few days, the agenda spanned industry roundtables, focused seminars and one-on-one company meetings. For Taiwanese companies, it was a rare chance to hear directly from practitioners on the front lines of the U.S. market. For the visiting professionals, it was an opportunity to gain a closer view of Taiwan’s technological strengths, innovative capacity and ambitions on the global stage.
Hall Chadwick Taiwan (耀風會計師事務所) was honored to help coordinate part of the team’s program in Taiwan and to participate in the exchanges. In just a few days, the agenda spanned industry roundtables, focused seminars and one-on-one company meetings. For Taiwanese companies, it was a rare chance to hear directly from practitioners on the front lines of the U.S. market. For the visiting professionals, it was an opportunity to gain a closer view of Taiwan’s technological strengths, innovative capacity and ambitions on the global stage.
From Cocktail Reception to BIO Asia: A Closer Look at Taiwan’s Corporate Scene
Sullivan & Worcester LLP’s visit to Taiwan was about much more than attending a single exhibition. On July 14, the team hosted a cocktail reception in Taipei, bringing together Taiwanese companies, industry leaders and professionals for an evening of networking and conversation. In a relaxed setting, participants from different sectors were able to exchange views on markets and share their international expansion experience, while the event itself underscored how seriously Sullivan & Worcester LLP views the Taiwanese market and the growth potential of Taiwanese companies.
On July 16, the Sullivan & Worcester LLP team hosted a half-day satellite symposium at BIO Asia–Taiwan. Drawing on first-hand experience with U.S. law and the U.S. capital markets, the speakers (representing various segments of the capital markets industry) walked companies through key issues to consider when expanding into the United States, raising cross-border capital and entering U.S. public markets.
In addition to the open seminar, the program also featured one-on-one consultation sessions between companies and the visiting team, with all available slots fully booked. The questions and discussions made it clear that Taiwanese companies are paying close attention to U.S. fundraising options, international capital markets and global expansion strategies.
Although the event was anchored in BIO Asia–Taiwan and naturally highlighted biotech and life sciences, the conversations around capital markets, cross-border growth and corporate internationalization reached well beyond any single industry.
On July 16, the Sullivan & Worcester LLP team hosted a half-day satellite symposium at BIO Asia–Taiwan. Drawing on first-hand experience with U.S. law and the U.S. capital markets, the speakers (representing various segments of the capital markets industry) walked companies through key issues to consider when expanding into the United States, raising cross-border capital and entering U.S. public markets.
In addition to the open seminar, the program also featured one-on-one consultation sessions between companies and the visiting team, with all available slots fully booked. The questions and discussions made it clear that Taiwanese companies are paying close attention to U.S. fundraising options, international capital markets and global expansion strategies.
Although the event was anchored in BIO Asia–Taiwan and naturally highlighted biotech and life sciences, the conversations around capital markets, cross-border growth and corporate internationalization reached well beyond any single industry.
.jpg)
.jpeg)
Seeing in Taiwan the Energy Israel Had 15 Years Ago
During the visit, David Danovitch, a senior partner at Sullivan & Worcester LLP, shared an observation that left a strong impression. After speaking directly with a range of Taiwanese companies and industry leaders, he remarked that this trip to Taiwan reminded him of Israel roughly fifteen years ago—when the market was full of companies with strong technical capabilities, a clear entrepreneurial mindset and a serious ambition to go global. He felt a similar level of energy and potential in the Taiwanese companies he met something he emphasized the U.S. Capital Markets were looking for – even desperately seeking.
For anyone looking at Taiwan through an investment lens, that comparison is worth pausing on. Israel has long been recognized for its technology innovation and vibrant startup ecosystem, with many companies scaling their technology and commercial value through international capital, cross-border partnerships and access to global markets.
Today, Taiwan is showing a comparable trajectory. Beyond its already world-leading sectors—such as semiconductors, ICT and advanced manufacturing—new players in biotech and healthcare, AI and other emerging technologies are steadily building the capacity to compete and grow on an international stage.
For anyone looking at Taiwan through an investment lens, that comparison is worth pausing on. Israel has long been recognized for its technology innovation and vibrant startup ecosystem, with many companies scaling their technology and commercial value through international capital, cross-border partnerships and access to global markets.
Today, Taiwan is showing a comparable trajectory. Beyond its already world-leading sectors—such as semiconductors, ICT and advanced manufacturing—new players in biotech and healthcare, AI and other emerging technologies are steadily building the capacity to compete and grow on an international stage.
As Taiwan’s technology, talent and innovation capabilities continue to mature, the next question naturally follows: how can these strengths be brought clearly into view for international capital, strategic partners and global markets?
That, in many ways, is what made this Sullivan & Worcester LLP visit so meaningful. It was not only about bringing first-hand U.S. market experience to Taiwan, but also about giving professionals who operate daily in international markets a chance to step into Taiwan’s industries, meet companies face-to-face and see for themselves the next wave of potential now taking shape.
From BIO Asia–Taiwan to Taiwan’s Other Strengths
Taiwan’s story does not end with biotech. From semiconductors and ICT to AI, advanced manufacturing and a range of emerging sectors, many Taiwanese companies are now thinking about their next phase of global expansion—and how best to leverage international capital, cross-border partnerships and professional support to sustain that growth.
During the visit, the Sullivan & Worcester LLP team also floated the idea of returning to Taiwan next year in connection with COMPUTEX. If that materializes, the dialogue that began at BIO Asia–Taiwan could naturally extend beyond biotech and life sciences into technology, AI, ICT and other Taiwanese industries that are already competing on a truly global stage.
For Hall Chadwick Taiwan, being part of this journey has been a rare and valuable experience in international collaboration. The true value did not lie in any single event, but in the series of genuine conversations that allowed international professionals to gain a deeper understanding of Taiwan—while giving Taiwanese companies direct exposure to first-hand perspectives from different markets.
When companies move toward the U.S. market, the real challenge often goes beyond capital and commercial opportunities. The harder part is learning how to navigate the differences in legal and regulatory frameworks, business culture and management mindset between Taiwan and the United States. Through its collaboration with Sullivan & Worcester LLP, Hall Chadwick Taiwan aims to combine both firms’ strengths in the Taiwan and U.S. markets, helping Taiwanese companies enter the U.S. more smoothly, reduce the friction created by regulatory and cultural differences, and build a path that runs from initial market entry and stable on-the-ground operations through to a solid foundation for long-term growth.
From BIO Asia–Taiwan to future cross-industry exchanges, our hope is that each cross-border dialogue will help the world see a little more of Taiwan—and help Taiwanese companies build a few more meaningful connections with the rest of the world.
During the visit, the Sullivan & Worcester LLP team also floated the idea of returning to Taiwan next year in connection with COMPUTEX. If that materializes, the dialogue that began at BIO Asia–Taiwan could naturally extend beyond biotech and life sciences into technology, AI, ICT and other Taiwanese industries that are already competing on a truly global stage.
For Hall Chadwick Taiwan, being part of this journey has been a rare and valuable experience in international collaboration. The true value did not lie in any single event, but in the series of genuine conversations that allowed international professionals to gain a deeper understanding of Taiwan—while giving Taiwanese companies direct exposure to first-hand perspectives from different markets.
When companies move toward the U.S. market, the real challenge often goes beyond capital and commercial opportunities. The harder part is learning how to navigate the differences in legal and regulatory frameworks, business culture and management mindset between Taiwan and the United States. Through its collaboration with Sullivan & Worcester LLP, Hall Chadwick Taiwan aims to combine both firms’ strengths in the Taiwan and U.S. markets, helping Taiwanese companies enter the U.S. more smoothly, reduce the friction created by regulatory and cultural differences, and build a path that runs from initial market entry and stable on-the-ground operations through to a solid foundation for long-term growth.
From BIO Asia–Taiwan to future cross-industry exchanges, our hope is that each cross-border dialogue will help the world see a little more of Taiwan—and help Taiwanese companies build a few more meaningful connections with the rest of the world.
Further Reading | Taiwan’s Global Opportunities in the U.S. Markets (Part 2): A Field Report on Sullivan & Worcester LLP’s New York Team Visit to Taiwan
.JPG)
.jpg)
.jpg)